TD Private Client Wealth’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4K | Buy |
956
+743
| +349% | +$20.5K | ﹤0.01% | 947 |
|
|
2025
Q1 | $6.04K | Buy |
213
+176
| +476% | +$4.99K | ﹤0.01% | 1059 |
|
|
2024
Q4 | $1.54K | Sell |
37
-302
| -89% | -$12.6K | ﹤0.01% | 1218 |
|
|
2024
Q3 | $22.7K | Sell |
339
-220
| -39% | -$14.7K | ﹤0.01% | 954 |
|
|
2024
Q2 | $66.4K | Buy |
559
+131
| +31% | +$15.6K | ﹤0.01% | 757 |
|
|
2024
Q1 | $45.6K | Sell |
428
-218
| -34% | -$23.2K | ﹤0.01% | 829 |
|
|
2023
Q4 | $64.2K | Sell |
646
-293
| -31% | -$29.1K | ﹤0.01% | 777 |
|
|
2023
Q3 | $97K | Sell |
939
-5,061
| -84% | -$523K | ﹤0.01% | 657 |
|
|
2023
Q2 | $729K | Sell |
6,000
-220
| -4% | -$26.7K | 0.03% | 386 |
|
|
2023
Q1 | $955K | Sell |
6,220
-2,462
| -28% | -$378K | 0.04% | 335 |
|
|
2022
Q4 | $1.56M | Sell |
8,682
-1,979
| -19% | -$355K | 0.07% | 254 |
|
|
2022
Q3 | $1.26M | Sell |
10,661
-188
| -2% | -$22.2K | 0.06% | 269 |
|
|
2022
Q2 | $1.55M | Buy |
10,849
+10,400
| +2,316% | +$1.49M | 0.08% | 245 |
|
|
2022
Q1 | $77.3K | Buy |
449
+412
| +1,114% | +$71K | ﹤0.01% | 687 |
|
|
2021
Q4 | $9.4K | Sell |
37
-322
| -90% | -$81.8K | ﹤0.01% | 914 |
|
|
2021
Q3 | $138K | Buy |
359
+330
| +1,138% | +$127K | 0.01% | 582 |
|
|
2021
Q2 | $6.81K | Hold |
29
| – | – | ﹤0.01% | 934 |
|
|
2021
Q1 | $3.8K | Sell |
29
-289
| -91% | -$37.8K | ﹤0.01% | 946 |
|
|
2020
Q4 | $33.2K | Hold |
318
| – | – | ﹤0.01% | 716 |
|
|
2020
Q3 | $22.5K | Buy |
318
+175
| +122% | +$12.4K | ﹤0.01% | 719 |
|
|
2020
Q2 | $9.18K | Buy |
143
+7
| +5% | +$449 | ﹤0.01% | 806 |
|
|
2020
Q1 | $4.07K | Buy |
136
+72
| +113% | +$2.16K | ﹤0.01% | 828 |
|
|
2019
Q4 | $1.25K | Buy |
+64
| New | +$1.25K | ﹤0.01% | 940 |
|